# Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss

> **NCT00802425** · PHASE2 · COMPLETED · sponsor: **Auris Medical AG** · enrollment: 210 (actual)

## Conditions studied

- Hearing Loss

## Interventions

- **DRUG:** AM-111
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00802425
- **Lead sponsor:** Auris Medical AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2012-07
- **Final completion:** 2012-10
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2014-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00802425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00802425, "Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00802425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*